Difference between revisions of "About-cancer/treatment/drugs/caplacizumab-yhdp"
(Marked this version for translation) |
|||
| Line 1: | Line 1: | ||
<languages/> | <languages/> | ||
<translate> | <translate> | ||
| − | == Caplacizumab-yhdp == | + | == Caplacizumab-yhdp == <!--T:1--> |
| + | <!--T:2--> | ||
This page contains brief information about caplacizumab-yhdp and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials. | This page contains brief information about caplacizumab-yhdp and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials. | ||
| + | <!--T:3--> | ||
'''US Brand Name(s)''' | '''US Brand Name(s)''' | ||
| + | <!--T:4--> | ||
Cablivi | Cablivi | ||
| + | <!--T:5--> | ||
'''FDA Approved''' | '''FDA Approved''' | ||
| + | <!--T:6--> | ||
Yes | Yes | ||
| + | <!--T:7--> | ||
FDA label information for this drug is available at DailyMed. | FDA label information for this drug is available at DailyMed. | ||
| + | <!--T:8--> | ||
'''Use in Cancer''' | '''Use in Cancer''' | ||
| + | <!--T:9--> | ||
Caplacizumab-yhdp is approved to treat: | Caplacizumab-yhdp is approved to treat: | ||
| + | <!--T:10--> | ||
*'''Acquired thrombotic thrombocytopenic purpura''' (aTTP) in adults. It is used with plasma exchange and immunosuppressive therapy. | *'''Acquired thrombotic thrombocytopenic purpura''' (aTTP) in adults. It is used with plasma exchange and immunosuppressive therapy. | ||
| + | <!--T:11--> | ||
'''More About Caplacizumab-yhdp''' | '''More About Caplacizumab-yhdp''' | ||
| + | <!--T:12--> | ||
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug. | Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug. | ||
| + | <!--T:13--> | ||
'''Clinical Trials Accepting Patients''' | '''Clinical Trials Accepting Patients''' | ||
| + | <!--T:14--> | ||
Find Clinical Trials for Caplacizumab-yhdp - Check for trials from NCI's list of cancer clinical trials now accepting patients. | Find Clinical Trials for Caplacizumab-yhdp - Check for trials from NCI's list of cancer clinical trials now accepting patients. | ||
| + | <!--T:15--> | ||
'''Important:''' The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug. | '''Important:''' The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug. | ||
</translate> | </translate> | ||
Latest revision as of 21:18, 29 October 2019
Caplacizumab-yhdp
This page contains brief information about caplacizumab-yhdp and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
US Brand Name(s)
Cablivi
FDA Approved
Yes
FDA label information for this drug is available at DailyMed.
Use in Cancer
Caplacizumab-yhdp is approved to treat:
- Acquired thrombotic thrombocytopenic purpura (aTTP) in adults. It is used with plasma exchange and immunosuppressive therapy.
More About Caplacizumab-yhdp
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Clinical Trials Accepting Patients
Find Clinical Trials for Caplacizumab-yhdp - Check for trials from NCI's list of cancer clinical trials now accepting patients.
Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
